July 2021
Sonic Healthcare USA to Offer Assay to Aid in the Selection of JEMPERLI (dostarlimab-gxly) Therapy in Endometrial Cancer
Sonic Healthcare USA Anatomic Pathology Division
07/02/2021
Sonic Healthcare USA to Offer Assay to Aid in the Selection of JEMPERLI (dostarlimab-gxly) Therapy in Endometrial Cancer
April 2021
Sonic Healthcare USA is announced as a Laboratory Testing Partner for National K-12 School Testing Program
Sonic Healthcare USA Anatomic Pathology Division
04/19/2021
Sonic Healthcare USA is announced as a Laboratory Testing Partner for National K-12 School Testing Program
July 2020
Over the last few weeks, our network of clinical laboratories throughout the United States has seen a significant increase in demand for COVID-19 molecular testing.
A new validation study published today, “Thyroid Cytology Smear Slides: An Untapped Resource for ThyroSeq Testing."
September 2020
Today, Sonic Healthcare USA (Sonic) was awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics Advanced Technology Platforms (RADx-ATP) initiative.
October 2020
Sonic Healthcare USA has launched a multiplex RT-PCR assay that combines testing for SARS-CoV-2 (COVID-19) and Influenza A/B with a single specimen collection.
December 2021
SARS-CoV-2 Omicron Variant of Concern
12/22/2021
SARS-CoV-2 Omicron Variant of Concern
July 2022
Sonic Healthcare USA (Sonic) was selected as one of five commercial laboratories authorized by the US Department of Health and Human Services (HHS)...
This week, Sonic Healthcare USA (Sonic) began testing for Monkeypox (MPXV), using the Centers for Disease Control and Prevention (CDC) Non-variola Orthopoxvirus, high complexity NAAT (RT-PCR) molecular assay...